Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Element Drive (Hangzhou) Biotechnology

Request full access

Specializing in R&D services for biochemical products, bio-feed, bio-based materials, and industrial enzyme preparations

ChinaFounded 2021Biotech & Life Sciences

About Element Drive (Hangzhou) Biotechnology

Element Drive (Hangzhou) Biotechnology Co., Ltd. is a synthetic biology company established in July 2021 as a key incubation project of West Lake University's Future Industry Research Center. The company focuses on the development and industrialization of biodegradable materials and soybean meal-free diet technology.

The company was founded by Dr. Zhang Kechun and Liu Minhao. Dr. Zhang, the chief scientist, holds a PhD from the California Institute of Technology where he studied under synthetic biology leader David A. Tirrell. Before returning to China, he was a tenured professor at the University of Minnesota with over 20 years of research experience in synthetic biology. Co-founder and Chairman Liu Minhao also serves as a special advisor to the president of West Lake University and has been instrumental in the university's development and the translation of scientific research into commercial applications.

Element Drive operates on a B2B model, developing and producing materials for downstream enterprises. A core part of its operations is its proprietary R&D platform, MiNT X, which utilizes enzyme engineering and metabolic pathways for predictable design, enabling the entire chain of biological intelligent manufacturing from R&D to production and product transformation. The company's revenue is generated through the sale of its developed materials and products. One of its key products is a novel biodegradable material, PiX, which boasts high strength, heat resistance, and toughness at a cost comparable to petroleum-based materials. This material is used in applications such as agricultural films, catering products, and express packaging. Another major focus is the production of synthetic amino acids for soybean meal-free animal diets, which addresses the fluctuating costs of imported soybeans for feed protein. This has led to a collaboration with Muyuan Foods to produce these diets.

The company has secured significant funding, including a Series A round of nearly 200 million RMB in October 2024, with investors like Hangzhou City Investment, China Merchants Venture Capital, West Lake Education Foundation, and Cloud Nine Capital. These funds are allocated for further technology R&D and market expansion. Element Drive is expanding its production capabilities, with a new facility for biodegradable materials in Jiande expected to start operations by the end of 2025, and a joint factory with Muyuan Foods for synthetic biology products under construction in Henan.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
22.7/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Oct 2024 $28M $110M China Merchants Group · Sky9 Capital ↗
SPINOUTOther financing Jan 2021 $0 — ShanghaiTech University —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Element Drive (Hangzhou) Biotechnology website traffic

Latest recorded traffic for Element Drive (Hangzhou) Biotechnology is 40 monthly website visits.

Latest monthly visits40
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Element Drive (Hangzhou) Biotechnology in its local ecosystem

Live from Dealroom

The Element Drive (Hangzhou) Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • China Merchants Group
  • Sky9 Capital

Other known investors1 additional known investor

  • ShanghaiTech University
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Element Drive (Hangzhou) Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Element Drive (Hangzhou) Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.